بررسی ارتباط دیابت بارداری با سرطان آندومتر

نوع مقاله : اصیل پژوهشی

نویسندگان

1 دانشجوی کارشناسی ارشد مامایی، کمیته تحقیقات دانشجویی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.

2 مربی گروه مامایی، مرکز تحقیقات مامایی و بهداشت باروری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.

3 استادیار گروه مامایی و بهداشت باروری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.

4 استادیار گروه رادیوتراپی و انکولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.

5 استادیار گروه آمار حیاتی، دانشکده پیراپزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.

چکیده

مقدمه: سرطان آندومتر، شایع‌ترین سرطان دستگاه تناسلی زنان در سراسر جهان محسوب می‌شود. میزان سرطان آندومتر در ایران رو به گسترش است. عوامل مختلفی بر بروز سرطان آندومتر مؤثر است. نقش دیابت بارداری در این عوامل نامشخص می‌باشد، لذا مطالعه حاضر با هدف مقایسه سابقه دیابت بارداری در زنان مبتلا و غیرمبتلا به سرطان آندومتر انجام شد.
روش‌کار: این پژوهش تحلیلی گذشته‌نگر بر روی 360 زن در سال 1396 مراجعه‌کننده به بیمارستان‌های تحت پوشش دانشگاه شهید بهشتی شهر تهران انجام گرفت. جمع‌آوری اطلاعات از طریق مصاحبه و تکمیل پرسشنامه‌های مشخصات جمعیت‌شناختی، باروری، سوابق پزشکی و اطلاعات مربوط به سرطان آندومتر بود. تجزیه و تحلیل داده‌ها با استفاده از نرم‌افزار آماری SPSS (نسخه 21) و آزمون‌های تی مستقل، کای دو، نسبت شانس و رگرسیون لوجستیک انجام گرفت. میزانp کمتر از 05/0 معنی‌دار در نظر گرفته شد.
یافته‌ها: در این مطالعه در مجموع 29 نفر (8%) سابقه دیابت بارداری داشتند که 17 نفر (2/14%) در گروه مورد و 12 نفر (5%) در گروه کنترل بودند. بین دو گروه مبتلا و غیرمبتلا به سرطان آندومتر از نظر دیابت بارداری تفاوت آماری معنی‌داری وجود داشت (05/0>p).
نتیجه‌گیری: وجود سابقه‌ دیابت بارداری باعث افزایش خطر سرطان آندومتر می‌گردد؛ بنابراین می‌تواند جهت پیشگیری اولیه و تشخیص زودرس سرطان آندومتر به‌کار رود.

کلیدواژه‌ها

عنوان مقاله [English]

Relationship between gestational diabetes and endometrial cancer

نویسندگان [English]

  • Zohreh Yeganeh 1
  • Zohre Sheikhan 2
  • Nourossadat Kariman 3
  • Parasto Hajian 4
  • Malihe Nasiri 5
1 M.Sc. student of Midwifery, Student Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2 Instructor, Department of Midwifery, Midwifery and Reproductive Health Research Center, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3 Assistant Professor, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4 Assistant Professor, Department of Radiotherapy and Oncology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5 Assistant Professor, Department of Biostatics, School of Paramedicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
چکیده [English]

Introduction: Endometrial cancer is the most common gynecological malignancy in women worldwide. The rate of endometrial cancer is increasing in Iran. Various factors affect the incidence of endometrial cancer. The role of gestational diabetes in these factors is unclear. Therefore, this study was performed with aim to compare the history of gestational diabetes in women with endometrial cancer and healthy women.
Methods: This retrospective analytical study was performed on 360 women referring to hospitals of Shahid Beheshti University of Medical Sciences in Tehran in 2017. Data was collected by interview and completing the questionnaire of demographic, fertility characteristics, medical records and endometrial cancer information. Data were analyzed by SPSS software (version 21) and Chi-square, independent t-test, Odds ratio and Logistic Regression. P<0.05 was considered statistically significant.
Results: In this study, 29 women (8%) had history of gestational diabetes that 17 women (14.2%) were in case group and 12 (5%) in control group. There was significant difference between two groups of women with endometrial cancer and healthy women in terms of gestational diabetes (p<0.05).
Conclusion: History of gestational diabetes increases the risk of endometrial cancer; therefore it can be used for primary prevention and early diagnosis of endometrial cancer.

کلیدواژه‌ها [English]

  • Endometrial cancer
  • Gestational diabetes
  • Iran

مراجع

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics. CA Cancer J Clin 2015; 65(2):87-108.
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2015; 65(1):5-29.
  3. Yazdani S, Bouzari Z, Naeimirad M. Epidemiology of endometrial cancer in north of Iran. Basic Clin Canc Res 2017; 8(4):37-41.
  4. Rezaianzadeh A, Dehghani SL, Mousavi M, Rezaeianzadeh R. The incidence of uterus cancer in Iran: a systematic review. Womens Health 2016; 4:e42917.
  5. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet 2016; 387(10023):1094-108.
  6. Grabner M. BMI trends, socioeconomic status, and the choice of dataset. Obes Facts 2012; 5(1):112-26.
  7. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010; 127(2):442-51.
  8. Liao C, Zhang D, Mungo C, Tompkins DA, Zeidan AM. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecol Oncol 2014; 135(1):163-71.
  9. Zhang ZH, Su PY, Hao JH, Sun YH. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer 2013; 23(2):294-303.
  10. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 2011; 47(13):1928-37.
  11. Guraya SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review. World J Gastroenterol 2015; 21(19):6026-31.
  12. Huang W, Ren H, Ben Q, Cai Q, Zhu W, Li Z. Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Cancer Causes Control 2012; 23(2):263-72.
  13. Ge Z, Ben Q, Qian J, Wang Y, Li Y. Diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies. Eur J Gastroenterol Hepatol 2011; 23(12):1127-35.
  14. Li X, Wang X, Gao P. Diabetes Mellitus and risk of hepatocellular carcinoma. Biomed Res Int 2017; 2017:5202684.
  15. Ren HB, Yu T, Liu C, Li YQ. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 2011; 22(6):837-47.
  16. Bao C, Yang X, Xu W, Luo H, Xu Z, Su C, et al. Diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis. J Diabetes Complications 2013; 27(4):357-64.
  17. Zhou Y, Zhang X, Gu C, Xia J. Diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction. Panminerva Med 2015; 57(3):101-8.
  18. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017; 389(10085):2239-51.
  19. Bishop EA, Lightfoot S, Thavathiru E, Benbrook DM. Insulin exerts direct effects on carcinogenic transformation of human endometrial organotypic cultures. Cancer Invest 2014; 32(3):63-70.
  20. Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci 2010; 118(5):315-32.
  21. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295(11):1288-99.
  22. Fritz MA, Sperrof L. Clinical gynecologic and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. P. 432.
  23. Papaioannou S, Tzafettas J. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer. Best Pract Res Clin Obstet Gynaecol 2010; 24(1):19-27.
  24. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005; 14(12):2840-7.
  25. Chandrasekaran K, Swaminathan K, Chatterjee S, Dey A. Apoptosis in HepG2 cells exposed to high glucose. Toxicol In Vitro 2010; 24(2):387-96.
  26. Zhang Y, Zhou J, Wang T, Cai L. High level glucose increases mutagenesis in human lymphoblastoid cells. Int J Biol Sci 2007; 3(6):375-9.
  27. Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 2008; 98(9):1582-5.
  28. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007; 16(2):276-80.
  29. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007; 50(7):1365-74.
  30. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159(12):1160-7.
  31. Zare Rashkooeih, Rezaeian RM, Rahnama A, Manshori M, Salajeghe M, Arab Baniasadi F, et al. Prevalence of pathological specimens of diagnostic curettage in patients admitted to Niknafs Hospital (A Short Report). J Rafsanjan Univ Med Sci 2012; 11(4):411-6.
  32. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007; 30(2):141-6.
  33. Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence--effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 2015; 213(3):310-7.
  34. Nguyen CL, Pham NM, Binns CW, Duong DV, Lee AH. Prevalence of gestational diabetes mellitus in eastern and southeastern Asia: a systematic review and meta-analysis. J Diabetes Res 2018; 2018:6536974.
  35. Albrecht SS, Kuklina EV, Bansil P, Jamieson DJ, Whiteman MK, Kourtis AP, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care 2010; 33(4):768-73.
  36. Sayehmiri F, Bakhtyari S, Darvishi P, Sayehmiri K. Prevalence of gestational diabetes mellitus in Iran: a systematic review and meta-analysis study. Iran J Obstet Gynecol Infertil 2013; 15(40):16-23. (Persian).
  37. Bouzari ZS, Yazdani SH, Abedi Samakosh M, Mohammadnetaj M, Emamimeybodi S. Prevalence of gestational diabetes and its risk factors in pregnant women referred to health centers of Babol, Iran, from September 2010 to March 2012. Iran J Obstet Gynecol Infertil 2013; 43(16):6-13. (Persian).
  38. Wartko PD, Beck TL, Reed SD, Mueller BA, Hawes SE. Association of endometrial hyperplasia and cancer with a history of gestational diabetes. Cancer Causes Control 2017; 28(8):819-28.
  39. Fuchs O, Sheiner E, Meirovitz M, Davidson E, Sergienko R, Kessous R. The association between a history of gestational diabetes mellitus and future risk for female malignancies. Arch Gynecol Obstet 2017; 295(3):731-6.
  40. Bejaimal SA, Wu CF, Lowe J, Feig DS, Shah BR, Lipscombe LL. Short‐term risk of cancer among women with previous gestational diabetes: a population‐based study. Diabetic Med 2016; 33(1):39-46.
  41. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19(12):3119-30.
  42. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Amer Inst Cancer Res 2007; 87(4):112-94.
  43. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371(9612):569-78.
  44. Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 2005; 97(2):422-30.
  45. Al-Azzawi F, Palacios S. Hormonal changes during menopause. Maturitas 2009; 63(2):135-7.
  46. Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006; 55(3):233-44.
  47. Maggino T, Pirrone F, Velluti F, Bucciante G. The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias. Eur J Gynaecol Oncol 1993; 14(2):119-26.
  48. Chodick G, Zucker I. Diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms. Womens Health 2011; 7(2):227-37.
  49. Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, Porath A, et al. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 2010; 21(6):879-87.
  50. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, et al. Diabetes and endometrial cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 2001; 10(6):611-6.
  51. Luo J, Beresford S, Chen C, Chlebowski R, Garcia L, Kuller L, et al. Association between diabetes, diabetes treatment and risk of developing endometrial cancer. Br J Cancer 2014; 111(7):1432-9.
  52. Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 2016; 176(6):816-25.
  53. Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY, Duggan CR, et al. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 2012; 30(19):2314-26.
  54. Friedenreich CM, Neilson HK, Woolcott CG, McTiernan A, Wang Q, Ballard-Barbash R, et al. Changes in insulin resistance indicators, insulin-like growth factors, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer 2011; 18(3):357.
  55. Lucenteforte E, Bosetti C, Talamini R, Montella M, Zucchetto A, Pelucchi C, et al. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br J Cancer 2007; 97(7):995-8.
  56. Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, et al. Diabetes and endometrial cancer: an Italian case‐control study. Int J Cancer 1999; 81(4):539-42.
  57. Aune D, Sen A, Vatten LJ. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep 2017; 7:44808.
  58. Hamet P. Cancer and hypertension: a potential for crosstalk. J Hypertens 1997; 15(12 Pt 2):1573-7.
  59. Inoue M, Okayama A, Fujita M, Enomoto T, Tanizawa O, Ueshima H. A case‐control study on risk factors for uterine endometrial cancer in Japan. Jpn J Cancer Res 1994; 85(4):346-50.
  60. Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007; 20(4):370-7.
  61. Rossi R, Turco V, Origliani G, Modena MG. Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women. J Hypertens 2006; 24(10 ):2017-22.
  62. Petrakis D, Vassilopoulou L, Mamoulakis C, Psycharakis C, Anifantaki A, Sifakis S, et al. Endocrine disruptors leading to obesity and related diseases. Int J Environ Res Publ Health 2017; 14(10):128-118.
  63. Solomon CG, Willett WC, Rich-Edwards J, Hunter DJ, Stampfer MJ, Colditz GA, et al. Variability in diagnostic evaluation and criteria for gestational diabetes. Diabetes Care 1996; 19(1):12-6.
  64. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004; 57(10):1096-103.
مجله زنان، مامایی و نازایی ایران
دوره 22، شماره 3
خرداد 1398
صفحه 49-58

فایل ها

هم رسانی

ارجاع به این مقاله

آمار